Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 4bgq | 38R | Cyclin-dependent kinase-like 5 | 2.7.11.22 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 4bgq | 38R | Cyclin-dependent kinase-like 5 | 2.7.11.22 | 1.000 | |
| 4mq1 | 2C3 | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 2.7.12.1 | 0.468 | |
| 4bch | T7Z | Cyclin-dependent kinase 9 | 2.7.11.22 | 0.467 | |
| 3rak | 03Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.459 | |
| 3r9d | X6B | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.453 | |
| 2vu3 | LZE | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.449 | |
| 3c0g | 3AM | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.448 | |
| 3zdu | 38R | Cyclin-dependent kinase-like 3 | 2.7.11.22 | 0.441 |